ch 12 GU GYN Flashcards

1
Q

physiologic leukorrhea

A

physiologic; white clear flocculent discharge
-normal/healthy women of reproductive age
-1-2 tsp/day (antimicrobial/viral properties)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

vaginal pH

A

3.8-4.2
lactobiacilli makes lactic acid and Hydrogen peroxide and kills pathogens; resist infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

white curdy cottage cheese discharge

A

candida vulvovaginitis (candida albicans)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

candida vulvovaginitis: patient complaints:
pH?
KOH whiff test?
Microscopic exam on saline wet mount?

A

itching/burning discharge
pH: < 4.5 (usually)
KOH: absent
Micrscope: mycelia, budding yeast pseudohyphae with kOH prep

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

candida vulvovaginitis intervention

A

-azole antifungal (oral fluconazole [Diflucan] or vaginal miconazole [Monistat], terconazole [Terazol])

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

bacterial vaginosis (BV) discharge

A

thin, homogenous. white gray, adherent, often increased
-overgrowth of bacterial that exists in the vagina
etiology: unclear, likely polymicrobial a/s wit hG. vaginalis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

bacterial vaginosis patient complaints:
pH?
KOH whiff test?
Microscopic exam on saline wet mount?

A

foul odor, itching sometimes, discharge
pH? 5-7 (less lactobacilli to make the acid environment)
KOH: Present (fishy)
Microscopic exam on saline wet mount? >20 clue cell (vaginal epithelial cells) and few WBC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

bacterial vaginosis intervention

A

metronidazole (Metrogel) or oral Flagyl
clindamycin vaginal cream
ovules (Cleocin, oral tinidazole (Tindamax)
oral secnidazole (Solosec $$$)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

genitourinary syndrome of menopause (GSM) aka atrophic vaginitis
etiology? discharge?

A

-estrogen deficiency; women after menopause
-discharge is less and is scant, white clear
-more prone to infections and STI’s
-reversible with supplemental estrogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

GSM aka atrophic vaginitis complaints:
pH?
KOH whiff test?
Microscopic exam on saline wet mount?

A

itching/burning (can be entire urethra region but not UTI), discharge, but can have no sx’s
- > 5 (once estrogen leaves, lactobacilli leaves)
-KOH absent
-few lactobacilli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

GSM aka atrophic vaginitis intervention

A

give topical and/or vaginal estrogen IF symptomatic and/or recurrent UTI
if estrogen lvls go down= lacto goes down and includes urethra region. using topical estrogen, lacto recolonizes = fewer UTI

oral estrogen ALONE is NOT effective , can be effective WITH topical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

human herpes virus/herpes simplex 2
clinical findings

A

genital herpes
-with initial outbreak, painful ulceratedlesions, marked lymphadenopathy (ie: L mark inguinal lymphadenopathy if L labial ulcer)
-women: thin vaginal discharge if lesion IN vagina or introitus
-can be few lesions, sx’s vary
-can transmit even if asymptomatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

herpes simplex 2 intervention

A

1st line: oral valacylovir (Valtrex)
-acyclovir (Zovirax)
-famciclovir (Famvir)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

nongonococcal urethritis and cervicitis clinical findings

A

-irritative voiding sx’s; occassional mucopurulent discharge
-women: cervicitis common
-often w/o sx’s regardless of gender
-culture to see large # of WBC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

nongonococcal urethritis and cervicitis treatment

A

1st line: doxycycline 100 mg PO BID x 7 days
alt: azithromycin 1 g PO x1 or levofloxacin 500 mg PO QD x 7 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

nongonococcal urethritis and cervicitis organisms

A

chlamydia trachomatis
ureaplasma urealyticum
mycoplasma genitalium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

gonococcal urethritis and vaginitis causative organism

A

neisseria gonorrhaoeae (Gram - bacteria)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

gonococcal urethritis and vaginitis clinical findings

A

irritavei voiding sx’s, occasional purulent discharge
often w/o sx’s
-large # of WBC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

gonococcal urethritis and vaginitis treatment

A

1st line: ceftriazone 500 mg IM x 1 PLUS doxycycline 100 mg PO BID x 7 days IF chlamydia trachomatis infection has NOT been ruled out

alternative if cef not available: gentamicin 240 mg IM x1, azithromycin 2 g PO as single dose, or cefixime 800 mg PO x1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

trichomoniasis organism

A

trichomonas vaginalis (protozoan)
(protozoan pathogen)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

trichomoniasis clinical finding

A

dysuria
itching
vulvovaginal irritation
frothy yellow-green vaginal discharge (only 30% have tho)
strawberry spots: cervical petechial hemorrhage (only 30% have tho)
often NO symptoms

motile organisms and lots of WBC
alkaline pH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

trichomoniasis intervention

A

1st line:
female: metronidazole 500 mg PO BID x 7 days
males: metronidazole 2 g PO x 1
[not gel; need oral]

alt: tinidazole 2 g PO x 1
EDUCATE NO ALCOHOL FOR 24 HRS after metronidazole completion (abdominal pain!) or 72 hrs after completion of tinidazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

most chamydial infections occur in what age groups

A

teen and < 25 yrs old

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

acute UNcomplicated UTI (cystitis, urethrtis) in non pregnant women organisms

A

E. coli (gram - ) 75% of all UTI’s
Klebseilla
S saprophyticus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

acute UNcomplicated UTI (cystitis, urethrtis) in non pregnant women treatment

A

-if local E. coli resistance to TMP/SMX < 20% and no allergy, then give TMP/SMX-DS PO BID x 3 days
or ***choose-if local E coli resistance to TMP/SMX > 20% or sulfa allergy, give nitrofurantoin (Macrobid) 100 mg PO BID x 5 days
-ADD urinary analgesic phenazopyridine (Pyridium) PO for sx control (urethra inflammation lingers even after day 2 of therapy)

2nd line: levofloxacin, Augmentin, ciprofloxacin, cephalexin,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

which medication can’t be given if pt is allergic to sulfa?

A

bactrim (TMP-SMX)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

epididymo-orchitis in those 35 and under years old, most likely what organisms?

A

N gonorrhoeae
Chlamydia trachnomatis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

epididymo-orchitis clinical presentation

A

irritive voiding sx’s (frequency, hematuria, dysuria)
fever,
painful swelling of epididymis and scrotum
-infertility potential post infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

epididymo-orchitis treatment under 35 yrs old

A

ceftriaxone 500 mg IM x 1 PLUS doxycycline 100 mg PO BID x 10 d
-educate scrotal elevation to help with symptom relief (Preh’s sign)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Preh’s sign

A

relief of discomfort with scrotal elevation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

epididym-orchitis over 35 years old or anal sex partern, most likely organism?

A

entrobacteriaceae (coliforms) (think lower GU organsms)
exact same sx’s and infertility potential

32
Q

epididym-orchitis over 35 years old or anal sex partner treatment

A

Levofloxacin 750 mg PO QD or ofloxacin 300 mg PO BID x 10-14 days

33
Q

acute bacterial prostatits (< 35 years old) organisms & sx’s

A

N gonorrhoeae
Chamlydia trachomatis

-irritive voiding sx’s
-suprapubic, perineal pain
-fever
-tender, boggy prostate from DRE
-leukocytosis

34
Q

acute bacterial prostatitis (<35 years old) treatment

A

ceftriaxone 500 mg IM x1 or cefixime 400 mg PO x1 THEN doxycycline 100 mg PO BID x10 days

35
Q

acute bacterial prostatitis (uncomplicated disease in men with low risk for STI) organism

A

enterobacteriaceae (coliforms)
older men

-irritive voiding sx’s, suprapubic, perineal pain, fever,
-tender, boggy prostate from DRE
-leukocytosis

36
Q

acute bacterial prostatitis ( >35; uncomplicated disease in men with low risk for STI) treatment

A

ciprofloxacin or levofloxacin or TMP-SXM

37
Q

epididymo-orchitis or prostatitis? or both
irrititive voiding sx’s?
perineal pain (hurts when sit on chair)?
prehn’s sign?
usu with fever?
scrotal swelling?

A

irrititive voiding sx’s? both
perineal pain (hurts when sit on chair)? prostatitis
prehn’s sign? Epididymo-orchitis
usu with fever? both
scrotal swelling? Epididymo-orchitis

38
Q

balanitis

A

inflammation/swelling of head of penis

39
Q

genital candida albicans in men

A

balanitis
groin fold involvement
scrotal excoriation

40
Q

tinea cruris

A

aka jock itch
red rash upper bilateral thighs, groin, or vulva involvement ONLY

41
Q

benign prostatic hyperplasia (BPH) sx’s & management

A

lower urinary tract sx’s (nocturia, weak stream, urgency, incontinence, voiding difficulties)
- get UA, PSA
-alpha 1 receptor blockage (tamsulosin)

42
Q

normal prostate physical finding

A

firm (touching tip of nose), smooth, non tender

43
Q

acute prostatitis DRE finding

A

tender, boggy, indurated
(as firm as touching skin of cheekbone)

44
Q

prostate cancer DRE finding

A

nodular, firm, nontender
-malignant lesions are usu NOT palpable until advanced

45
Q

loss of urine with lifting, coughing, sneezing

A

stress incontinence

46
Q
A

transient continence
-there was an underlying condition

47
Q
A

urge incontinence
-sudden onset; overactive detruser muscle

48
Q

81 year old in wheelchair can’t use toilet w/o assistance

A

functional incontinence
-consider other meds like diuretics and wheelchair

49
Q

urge incontinence

A

-most common in older adults
-strong sensation of needing to empty bladder that cannot be suppressed
-involuntary loss of urine

50
Q

urge incontinence management

A

antimuscarinic (anticholinergic): tolterodine (Detrol), oxybutynin (Ditropan), solifenacin succinate (VESIcare), darifenacin (Enablex), fesoterodine fumarate (Toviaz)

AE: dry mouth, sedation, mental status change (in higher doses)

alts: Beta agonists: mirabegron (Myrbetriq), vibegron (Gemtesa) and botox injections to bladder

51
Q

stress incontinence

A

most common in women (men rare)
loss of urine with activity that causes inc and pressure (coughing, sneezing, exercise)

52
Q

functional incontinence management

A

having an assistance who can recognize voiding cues and help with toileting activities

53
Q

stress incontinence management

A

-support area via vaginal tampon, urethral stents, periurethral bulking agent injections, and pessary
-kegal exercises most helpful in younger, premenopausal women
-pelvic floor rehab with electrical stimulation and bladder training
-surgical intervention

54
Q

functional incontinence

A

inability to get to toilet or lack of awareness of need to void
-usu in mobility issues or altered cognition
-worsen by unavailability of a hleper to assist in toileting activities

55
Q

transient incontinence

A

-a/s with acute events (delirium, UTI, med use, restricted activity)

56
Q

transient incontinence management

A

treating underlying process, discontinuation of offending medication

57
Q

treatable causes of urinary incontinence

A

DIAPPERS
-delirium
-infection (urinary)
-atrophic urethritis and vaginitis
-pharmaceuticals (diuretics, others)
-psychologic disorders (depression)
-excessive urine output (heart failure, hyperglycemia due to undetected or poorly controlled DM)
-restricted mobility
-stool impaction

58
Q

no pap smears needed if

A

total hysterectomy including cervix

59
Q

if a pt acquires 1 hpv type (genital warts which is 6 & 11)

A

they’re more likely to get other types of HPV

60
Q

ovarian risk factors

A

post menopausal (older age)
obesity
nulliparity or 1st preg > 35 years
fertility drugs
using estrogen post menopause (>5-10 years)
family hx/genetics (BRCA1, BRCA2)
shared etiology with breast cancer

61
Q

ovarian cancer sx’s

A

non specific sx’s in early stage
-esp 50yrs old+x
-bloating
-bladder pressure, constipation, vaginal bleeding, indigestion, SOB, lethargy, weight loss

62
Q

ovarian cancer management

A

abdominal CT with contrast and pelvis, US, MRI
-tumor marker (cancer antigen 125)
-surgery then chemo

63
Q

cervical cancer causes

A

persistent infection with HPV:
70% are HPV 16 & 18
~20% HPV 31, 33, 52, 58

64
Q

cervical cancer clinical presentation

A

abnormal vaginal bleeding
vaginal discomfort during sex
malodour discharge, dysuria

typically asx with 1st abnormal pap result

64
Q

cervical cancer diagnostics and tx

A

pap test then colposcopy and bx
-pelvic CT and/or MRI or PET scan
-tx based on cancer stage
-surgery for early stage
-radiation /chemo for advanced

65
Q

endometrial cancer risk factors

A

older age
estrogen therapy
nulliparity
tamoxifen use (cancer risk < 1% per year)
hx of breast or ovarian cancer
PCOS
DM 2
family hx

66
Q

endometrial cancer clinical presentation

A

abnormal vaginal bleeding (post menopausal bleeding; or heavy frequent menstrual periods or intermenstrual bleeding in pre/perimenopausal women)

67
Q

endometrial cancer diagnostics

A

-transvaginal U/S
-hydroultrasonography
-hysterectomy
-endometrial biopsy
-fractional D&C

68
Q

endometrial cancer treatment

A

surgery then chemo w/ or w/o radiation

69
Q

cervical cancer screening in what ages?

A

start age 21 or 25 and stop 65 yrs

70
Q

do women with hysterecomy need cervical cancer screening?

A

total hysterecomty with cervical removal
can stop UNLESS hysterectomy was for cervical cancer or precancer (CIN 2 or 3)
-but if have hysterectomy with cervix still intact, continue screening guidelines

71
Q

women with hx of CIN 2 or CIN 3

A

continue cervical screening for at least 20 yrs (more frequent the first few yrs to make surer all cancer cells were removed)

72
Q

anal testing in men and women

A

routine testing NOT rec if asx
-test high risk: HIV, anal sex, hx of anal warts, hx of cervical or vulvar cancer
-test every year for HIV + and every 2-3 yrs for HIV negative

73
Q

antiretroviral therapy (ART)

A

HIV care in all adults/adolescents that are HIV +
-start ASAP after diagnosing
-lifelong

74
Q

preexposure prophylaxis (PrEP)

A

use of ART for high risk of being infected but don’t have HIV (sex, injection)
-start ASAP after a risk behavior assessment that determines they’re high risk of HIV and lab testing confirms absence of HIV infection
-daily treatment until risk of HIV is low from less exposure

75
Q

Postexposure prophylaxis (PEP)

A

use of ART after a single high risk event exposure (within 72 hrs) to minimize possibility of HIV seroconversion
-duration: 28 days